$1.78
0.031.71%
Pre-Market: 5:49 AM EDT
15 minutes delayed
Comments
Loading...
Esperion Therapeutics (ESPR) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEsperion Therapeutics (NASDAQ:ESPR) Stock Quotes, Forecast and News Summary
Esperion Therapeutics Stock (NASDAQ: ESPR) stock price, news, charts, stock research, profile.
| Open | - |
| Close | - |
| Volume / Avg. | 1.02K / 6.12M |
| Day Range | - - - |
| 52 Wk Range | 0.70 - 3.40 |
| Market Cap | $349.28M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 44 |
| Short Interest | 20.66% |
| Days to Cover | 11.8 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Esperion Therapeutics Inc.
Sector
Health Care
Industry
Pharmaceuticals
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializ...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Esperion Therapeutics (ESPR) stock?
You can purchase shares of Esperion Therapeutics (NASDAQ:ESPR) through any online brokerage.
Who are Esperion Therapeutics (ESPR) competitors?
Other companies in Esperion Therapeutics’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Third Harmonic Bio (NASDAQ:THRD), Zevra Therapeutics (NASDAQ:ZVRA), Theravance Biopharma (NASDAQ:TBPH) and GH Research (NASDAQ:GHRS).
What is the forecast, or price target, for Esperion Therapeutics (ESPR) stock?
Esperion Therapeutics has a consensus price target of $7.50.
What is the current price for Esperion Therapeutics (ESPR)?
The stock price for Esperion Therapeutics (NASDAQ: ESPR) is $1.78 last updated September 13, 2024 at 5:49 AM EDT.
Does Esperion Therapeutics (ESPR) pay a dividend?
There are no upcoming dividends for Esperion Therapeutics.
When is Esperion Therapeutics (NASDAQ:ESPR) reporting earnings?
Esperion Therapeutics’s Q3 earnings are confirmed for Tuesday, November 5, 2024.
Is Esperion Therapeutics (ESPR) going to split?
There is no upcoming split for Esperion Therapeutics.
What sector and industry does Esperion Therapeutics (ESPR) operate in?
Esperion Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.